Cassava Sciences Inc (SAVA)
26.48
-5.70
(-17.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.62
+0.14
(+0.53%)
After-Hours: 20:00
Cassava Sciences Price: 26.48 for Nov. 22, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 22, 2024 | 31.40 | 31.40 | 26.02 | 26.48 | 7.314M |
Nov 21, 2024 | 26.13 | 33.98 | 26.03 | 32.18 | 4.651M |
Nov 20, 2024 | 28.13 | 28.28 | 25.72 | 26.05 | 1.840M |
Nov 19, 2024 | 28.23 | 29.49 | 27.18 | 28.00 | 1.603M |
Nov 18, 2024 | 27.40 | 28.18 | 26.09 | 27.95 | 1.737M |
Nov 15, 2024 | 26.46 | 28.99 | 25.46 | 26.91 | 2.837M |
Nov 14, 2024 | 25.59 | 26.66 | 25.40 | 26.14 | 1.233M |
Nov 13, 2024 | 26.31 | 27.00 | 25.00 | 25.18 | 1.131M |
Nov 12, 2024 | 26.89 | 27.20 | 25.92 | 26.38 | 905809.0 |
Nov 11, 2024 | 27.76 | 28.18 | 26.77 | 27.06 | 1.191M |
Nov 08, 2024 | 25.00 | 27.98 | 24.75 | 26.95 | 2.036M |
Nov 07, 2024 | 26.42 | 27.16 | 24.64 | 25.34 | 1.653M |
Nov 06, 2024 | 24.64 | 27.03 | 23.90 | 26.57 | 1.949M |
Nov 05, 2024 | 25.54 | 25.70 | 23.46 | 23.93 | 1.909M |
Nov 04, 2024 | 26.41 | 26.70 | 25.45 | 25.84 | 1.008M |
Nov 01, 2024 | 25.81 | 26.25 | 25.55 | 26.21 | 1.384M |
Oct 31, 2024 | 25.80 | 26.19 | 24.80 | 25.80 | 1.437M |
Oct 30, 2024 | 26.30 | 26.62 | 25.86 | 26.00 | 1.178M |
Oct 29, 2024 | 26.70 | 26.82 | 26.15 | 26.52 | 784560.0 |
Oct 28, 2024 | 26.99 | 27.56 | 26.46 | 26.73 | 925809.0 |
Oct 25, 2024 | 27.25 | 27.75 | 26.51 | 26.55 | 1.207M |
Oct 24, 2024 | 28.06 | 28.29 | 26.95 | 27.29 | 965239.0 |
Oct 23, 2024 | 28.30 | 28.83 | 26.88 | 27.99 | 1.191M |
Oct 22, 2024 | 28.82 | 28.97 | 28.16 | 28.43 | 825120.0 |
Oct 21, 2024 | 29.00 | 29.60 | 28.32 | 28.88 | 881311.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.41
Minimum
Nov 25 2019
135.30
Maximum
Jul 28 2021
28.08
Average
24.13
Median
Price Benchmarks
Bristol-Myers Squibb Co | 58.87 |
Seelos Therapeutics Inc | 0.3001 |
EyePoint Pharmaceuticals Inc | 8.95 |
PTC Therapeutics Inc | 43.23 |
Adverum Biotechnologies Inc | 6.04 |
Price Related Metrics
PS Ratio | 29.06 |
Price to Book Value | 7.645 |
Earnings Yield | -5.21% |
Market Cap | 1.274B |
Operating PE Ratio | 38.09 |
Normalized PE Ratio | 5.563 |